Ask AI

Decoding Dual Action: Understanding Muscarinic Acetylcholine Receptors in Schizophrenia Management

Emerging research is reshaping schizophrenia care, offering pathways to address persistent symptoms while mitigating adverse events tied to traditional therapies. Interactive case discussions and clinical trial updates highlight new strategies to individualize treatment, improve adherence, and reduce psychosocial burdens for patients navigating the challenges of schizophrenia.

Share

Program Content

Events

Activities

Schizophrenia Care Management DL
Dopamine Detours: New Paths for Positive, Negative & Cognitive Symptoms
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: December 09, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Bristol Myers Squibb. 

Bristol Myers Squibb